je.st
news
Tag: merck
German drugmaker Merck sees Q4 net more than double to $355 million
2013-03-07 10:02:15| Biotech - Topix.net
Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.
Merck to Present at the 33rd Annual Cowen Health Care Conference
2013-03-05 14:30:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the 33rd Annual Cowen Health Care Conference in Boston on March 6 at 10:40 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. Language: English Contact HTML: MerckMedia:Ron Rogers, 908-423-6449orInvestors:Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
care
present
annual
Merck Scientist Daria Hazuda Presents Bernard Fields Lecture at 20th Conference on Retroviruses and Opportunistic Infections (CROI)
2013-03-04 15:59:27| Merck.com - Research & Development News
Dateline City: ATLANTA Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced its worldwide head of Antiviral Basic Research and internationally renowned scientist, Daria Hazuda, Ph.D., presented the annual Bernard Fields Lecture yesterday at the opening session of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta, Ga. Language: English Ticker Slug: Ticker: NYSE Exchange: NYSE read more
Tags: conference
fields
presents
bernard
Bio Box: Kenneth Frazier, CEO of drugmaker Merck
2013-03-04 07:38:45| Biotech - Topix.net
CAREER: Served in private practice for 16 years, including as a partner at Philadelphia's Drinker Biddle & Reath.
CEO: Risks key for Merck to succeed, help patients
2013-03-01 19:44:37| Biotech - Topix.net
Merck & Co. CEO Kenneth C. Frazier is convinced nearly everyone, from patients to long-term investors, wants the world's third-largest drugmaker to take big risks.
Sites : [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] next »